Table 1.
Antibody | Tumor Model | Tumor/Plasma Ratio | Cetuximab/8C2 |
---|---|---|---|
8C2 | LS174T | 0.26 | 1.58 |
Cetuximab | LS174T | 0.41 | - |
8C2 | LS174T/Sorafenib | 0.20 | 1.35 |
Cetuximab | LS174T/Sorafenib | 0.27 | - |
8C2 | NCI-N87 | 0.19 | 2.53 |
Cetuximab | NCI-N87 | 0.48 | - |
8C2 | Panc-1 | 0.08 | 1.50 |
Cetuximab | Panc-1 | 0.12 | - |